Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Helen Yarimet Lorenzo-Anota"'
Autor:
Kenny Misael Calvillo-Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez-Padilla, Ana Carolina Martínez-Torres, Daniel Scott-Algara
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cancer immunotherapies include monoclonal antibodies, cytokines, oncolytic viruses, cellular therapies, and other biological and synthetic immunomodulators. These are traditionally studied for their effect on the immune system’s role in eliminating
Externí odkaz:
https://doaj.org/article/5ad05fc728cf402aa91c595a4b53237e
Autor:
Helen Yarimet Lorenzo-Anota, Diana G. Zarate-Triviño, Jorge Alberto Uribe-Echeverría, Andrea Ávila-Ávila, José Raúl Rangel-López, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 942 (2021)
(1) Background: Chitosan-coated gold nanoparticles (CH-AuNPs) have important theranostic applications in biomedical sciences, including cancer research. However, although cell cytotoxicity has been studied in cancerous cells, little is known about th
Externí odkaz:
https://doaj.org/article/2a1edec5699e4184a984efc0f19d3456
Autor:
José Raúl Rangel-López, Diana G Zarate-Triviño, Andrea Ávila-Ávila, Ana Carolina Martínez-Torres, Jorge Alberto Uribe-Echeverría, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez-Padilla
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 942, p 942 (2021)
Volume 13
Issue 7
Pharmaceutics, Vol 13, Iss 942, p 942 (2021)
Volume 13
Issue 7
(1) Background: Chitosan-coated gold nanoparticles (CH-AuNPs) have important theranostic applications in biomedical sciences, including cancer research. However, although cell cytotoxicity has been studied in cancerous cells, little is known about th
Autor:
Diana G Zarate-Triviño, Martín García-Juárez, Ana Carolina Martínez-Torres, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez-Padilla
Publikováno v:
International Journal of Nanomedicine. 14:7173-7190
Background Nanotechnology proposes the use of gold nanoparticles (AuNPs) for drug delivery, diagnosis, and treatment of cancer. Leukemia is a type of hematopoietic cancer that results from the malignant transformation of white blood cells. Chitosan-c
Autor:
Cristina Rodríguez-Padilla, Ana Carolina Martínez-Torres, Reyes Tamez-Guerra, Helen Yarimet Lorenzo-Anota, Daniel Scott-Algara
Publikováno v:
Journal of Oncology
Journal of Oncology, Hindawi Publishing Corporation, 2020, 2020, pp.1598503. ⟨10.1155/2020/1598503⟩
Journal of Oncology, 2020, 2020, pp.1598503. ⟨10.1155/2020/1598503⟩
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology, Hindawi Publishing Corporation, 2020, 2020, pp.1598503. ⟨10.1155/2020/1598503⟩
Journal of Oncology, 2020, 2020, pp.1598503. ⟨10.1155/2020/1598503⟩
Journal of Oncology, Vol 2020 (2020)
Immunotherapies strengthen the immune system to fight multiple diseases such as infections, immunodeficiencies, and autoimmune diseases, and recently, they are being used as an adjuvant in cancer treatment. IMMUNEPOTENT-CRP (I-CRP) is an immunotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81538a45daa1db62032df6a0aa28c1a
https://hal-pasteur.archives-ouvertes.fr/pasteur-02861715
https://hal-pasteur.archives-ouvertes.fr/pasteur-02861715